Across TCGA pan-cancer cohorts, GADD45G RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated GADD45G data layer compared with 1 for mutation status.
The strongest signal is observed in uveal melanoma (UVM), where higher GADD45G RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GADD45G expression acts as an unfavorable survival marker, although some lineages such as LIHC and SARC show a favorable association.
UVM, LIHC, and SARC are the cancer types where GADD45G RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.